Metlife (MET) Liabilities and Shareholders Equity (2009 - 2026)

Metlife's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $743.2 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 151575.71% year-over-year to $743.2 billion in Q1 2026; TTM through Mar 2026 was $2910.6 billion, a 41.38% increase from a year earlier, with the FY2025 full-year figure at $745.2 billion, up 9.99% from the prior year.
• Liabilities and Shareholders Equity held at $743.2 billion in Q1 2026 per MET's latest filing, from $745.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $745.2 billion in Q4 2025 and bottomed at $490.0 million in Q1 2025.
• The 5-year median for Liabilities and Shareholders Equity is $677.5 billion (2024), against an average of $649.3 billion.
• Across the five-year window, Liabilities and Shareholders Equity tumbled 99.93% in 2025 and surged 151575.71% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $663.1 billion in 2022, then increased by 3.7% to $687.6 billion in 2023, then decreased by 1.47% to $677.5 billion in 2024, then gained by 9.99% to $745.2 billion in 2025, then slipped by 0.26% to $743.2 billion in 2026.
• Per Business Quant, the three latest MET Liabilities and Shareholders Equity figures stand at $743.2 billion (Q1 2026), $745.2 billion (Q4 2025), and $719.7 billion (Q3 2025).